Zacks Investment Management’s AngioDynamics ANGO Stock Holding History

Zacks Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,999	Closed	-$205K	–	600
2022 Q3	$205K	Buy	+9,999	New	+$220K	﹤0.01%	536
2022 Q2	–	Sell	-10,013	Closed	-$216K	–	569
2022 Q1	$216K	Sell	10,013 -951	-9%	-$21.6K	﹤0.01%	569
2021 Q4	$302K	Buy	+10,964	New	+$303K	﹤0.01%	536
2021 Q3	–	Sell	-44,235	Closed	-$1.2M	–	598
2021 Q2	$1.2M	Sell	44,235 -301	-0.7%	-$7.35K	0.02%	344
2021 Q1	$1.04M	Buy	+44,536	New	+$900K	0.02%	357
2017 Q3	–	Sell	-14,145	Closed	-$229K	–	578
2017 Q2	$229K	Sell	14,145 -2,450	-15%	-$38.7K	0.01%	518
2017 Q1	$288K	Buy	16,595 +22	+0.1%	+$368	0.01%	506
2016 Q4	$280K	Buy	+16,573	New	+$276K	0.01%	520
2015 Q1	–	Sell	-15,464	Closed	-$294K	–	620
2014 Q4	$294K	Buy	+15,464	New	+$262K	0.01%	513

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zacks Investment Management's ANGO Position: Q4 2022 in Review

Zacks Investment Management sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 9,999 shares — an estimated $205K sold.

Zacks Investment Management first reported a position in ANGO in Q4 2014 and held it in 9 quarters. The position peaked at $1.2M in Q2 2021. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

Zacks Investment Management reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
Zacks Investment Management sold 9,999 AngioDynamics shares in Q4 2022, an estimated $205K.
Zacks Investment Management first reported a position in AngioDynamics in Q4 2014 and held it in 9 quarters.
Zacks Investment Management's AngioDynamics position peaked at $1.2M in Q2 2021.
149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Zacks Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.